← board
ABVC
distress 6/10 · elevated risk$1.180%today-70% from 52w high
Revenue
pre-revenue
Liquidity
$2M
Runway
0.6 yrs
Shares 1y
+10%
Price & events
-43.3% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
-2.5%
1W
-9.9%
1M
+3.5%
3M
-42.7%
6M
-61.6%
1Y
+49.0%
2Y
-97.6%
5Y
-97.7%
All
Overview
- Market Cap
- $30.68M
- Volume
- 7.61K
- 52 Week Range
- $0.91 – $3.97
- Total Shares
- 26.00M
- Float Shares
- 20.44M
- Short %
- 1.73%
- % Held by Insiders
- 18.57%
- % Held by Institutions
- 3.14%
- RVOL
- 0.05x
- Beta
- 0.54
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.